Discovery and design of new drugs for cancer therapy can be based on different strategies, e.g., effect of a drug on extent and duration of apoptosis, or induced cytoskelatal changes affecting motility and invasiveness. Information underlying these strategies may be gathered using techniques comprising the emerging discipline of cytomics. Foremost of these, for our purposes, is High Content Screening (HCS). We propose to develop new nanoscale sensors suitable for HCS that will have multiple applications for development of new cancer drugs: at the highest level as a basic research tool for real-time three-dimensional in vivo cell imaging for screening of new cancer drugs, and at a finer level, as a tool for real-time imaging of targeteddrug carrier interaction with cell membranes. Ultimately, we envision these sensors being incorporated into the bottom of disposable cell-culture dishes. In this configuration, acquisition of real-time, high resolution (~30nm) image data over the entire volume of the cell culture from the array surface to a height of 10-20 microns would be performed simultaneously for a variety of physical parameters affecting or affected by cell physiology: surface charge, optical emision (i.e., fluorescent optical imaging), or physical strain induced by piezo-electric crystals embedded in the cell culture nano-array (i.e., ultrasonic imaging). Development of simultaneous in vivo, multimodal nano-volume imaging will be pursued along two parallel lines: conventional PZT (Lead-Zirconium-Titanate) based ultrasonic transduction reduced in size, and the other based on a novel sensor technology, offering potential improvements in sensitivity and scalability, at reduced cost. These will be based on the recent experimental observation that hybrid thin film structures possessing an appropriately selected geometric interface (between a semiconductor and a metal) display a new phenomenon that has been labeled extraordinary magneto-resistance (EMR). We have demonstrated that EMR devices are scalable from macroscopic to nanoscopic dimensions in the range of millimeters to 20 nm.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA119342-05
Application #
7930501
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2009-09-01
Budget End
2010-08-31
Support Year
5
Fiscal Year
2009
Total Cost
$338,119
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Pan, Dipanjan; Kim, Benjamin; Hu, Grace et al. (2015) A strategy for combating melanoma with oncogenic c-Myc inhibitors and targeted nanotherapy. Nanomedicine (Lond) 10:241-51
Goette, Matthew J; Keupp, Jochen; Rahmer, Jürgen et al. (2015) Balanced UTE-SSFP for 19F MR imaging of complex spectra. Magn Reson Med 74:537-43
Schmieder, Anne H; Caruthers, Shelton D; Keupp, Jochen et al. (2015) Recent Advances in (19)Fluorine Magnetic Resonance Imaging with Perfluorocarbon Emulsions. Engineering (Beijing) 1:475-489
Schmieder, Anne H; Winter, Patrick M; Williams, Todd A et al. (2013) Molecular MR imaging of neovascular progression in the Vx2 tumor with ?v?3-targeted paramagnetic nanoparticles. Radiology 268:470-80
Pan, Hua; Myerson, Jacob W; Hu, Lingzhi et al. (2013) Programmable nanoparticle functionalization for in vivo targeting. FASEB J 27:255-64
Wu, Lina; Luderer, Micah; Yang, Xiaoxia et al. (2013) Surface passivation of carbon nanoparticles with branched macromolecules influences near infrared bioimaging. Theranostics 3:677-86
Wu, Lina; Cai, Xin; Nelson, Kate et al. (2013) A Green Synthesis of Carbon Nanoparticle from Honey for Real-Time Photoacoustic Imaging. Nano Res 6:312-325
Hu, Lingzhi; Chen, Junjie; Yang, Xiaoxia et al. (2013) Rapid quantification of oxygen tension in blood flow with a fluorine nanoparticle reporter and a novel blood flow-enhanced-saturation-recovery sequence. Magn Reson Med 70:176-83
Hou, Kirk K; Pan, Hua; Lanza, Gregory M et al. (2013) Melittin derived peptides for nanoparticle based siRNA transfection. Biomaterials 34:3110-9
Hood, Joshua L; Jallouk, Andrew P; Campbell, Nancy et al. (2013) Cytolytic nanoparticles attenuate HIV-1 infectivity. Antivir Ther 18:95-103

Showing the most recent 10 out of 90 publications